Results 161 to 170 of about 105,631 (265)

Within-host co-evolution of KPC variants: plasmid-mediated dissemination of <i>bla</i>_Kpc-194 and <i>bla</i>_Kpc-33 in ST11-KL64 hypervirulent <i>Klebsiella pneumoniae</i> driving ceftazidime-avibactam resistance. [PDF]

Microbiol Spectr
Ding L, Wu X, Xie Q, Liu L, Liang B, Shen S, Guo Y, Chen J, Hu F.   +8 more
europepmc   +1 more source

One-Day Aminoglycosides versus Three-Day Ceftazidime for Perioperative Prophylaxis and Postoperative Sepsis Risk in Patients with Urinary Calculi: A Propensity Score-Matched Retrospective Cohort Analysis. [PDF]

Drug Des Devel Ther
Sun S, Guo J, Zhang Z, Guo D, Li J, Cai X.   +5 more
europepmc   +1 more source

Corrigendum: Reactive Oxygen Species-Related Ceftazidime Resistance Is Caused by the Pyruvate Cycle Perturbation and Reverted by Fe3+ in Edwardsiella tarda

Frontiers in Microbiology, 2021
Jinzhou Ye, Yubin Su, Xuanxian Peng, Xuanxian Peng, Hui Li, Hui Li   +5 more
doaj   +1 more source

The <i>bla_KPC-249</i> -mediated mechanism drives the transition of ST463 <i>Pseudomonas aeruginosa</i> from Ceftazidime-Avibactam sensitivity to resistance during clinical treatment. [PDF]

Front Cell Infect Microbiol
Li X, Feng Y, Wu X, Shen H, Shang S, Tang W, Hu F, Liang H.   +7 more
europepmc   +1 more source

Co-Administration Dosing of Ceftazidime-Avibactam and Aztreonam in Patients with Varying Renal Function for Carbapenem-Resistant Enterobacterales Infections via Monte Carlo Simulation. [PDF]

Infect Chemother
Hemapanpairoa J, Saelim W, Changpradub D, Santimaleeworagun W.   +3 more
europepmc   +1 more source

Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis. [PDF]

Elife
Kadeřábková N, Furniss RCD, Maslova E, Potter KE, Eisaiankhongi L, Bernal P, Filloux A, Landeta C, Gonzalez D, McCarthy RR, Mavridou DAI.   +10 more
europepmc   +1 more source

Ceftazidime-Avibactam-Induced Neurotoxicity Manifesting as Seizure in an Older Adult: A Case Report. [PDF]

Infect Drug Resist
Li Z, Li C, Zhao P, Han Y, Lu N.
europepmc   +1 more source

Suboptimal ceftazidime-avibactam exposure drives sequential <i>bla</i>_KPC mutations and intra-host coexistence of <i>Klebsiella pneumoniae</i> harboring distinct variants leading to persistent infection. [PDF]

Microbiol Spectr
Yang F, Yang W, Zhang J, Tang C, Ding L, Shen S, Zhou Y, Zhao H, Zhou J, Hu F.   +9 more
europepmc   +1 more source

Induction of colistin resistance and environmental toxicity assessment in Escherichia coli. [PDF]

PLoS One
Nunes Lima TH, de Souza M, Soares JM, Blanco KC, Salvador Bagnato EV.   +4 more
europepmc   +1 more source

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial.

Lancet. Infectious Diseases (Print), 2017
A. Torres, N. Zhong, J. Pachl, J. Timsit, M. Kollef, Zhangjing Chen, Jie Song, D. Taylor, P. Laud, G. Stone, J. Chow   +10 more
semanticscholar   +1 more source